Based on the brain transcriptomics and metabolomics of postmortem AD samples, higher ratio of GCDCA/CA and secondary BA (DCA, LCA, TDCA, and GDCA) were identified in AD patients compared with cognitively normal individuals [42]. Here, GNAT3 is linked to Alzheimer disease.